Clinical Edge Journal Scan

Atopic Dermatitis in Early Life Tied to Subsequent Risk for Inflammatory Bowel Disease


 

Key clinical point: Children with atopic dermatitis (AD) at age 3 years showed an increased subsequent risk of developing inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC); however, atopic manifestations were not associated with IBD.

Major finding: The presence of AD at age 3 years significantly increased the risk for IBD (pooled adjusted hazard ratio [aHR] 1.46; 95% CI 1.13-1.88), CD (pooled aHR 1.53; 95% CI 1.04-2.26), and UC (pooled aHR 1.78; 95% CI 1.15-2.75) later in life. Any atopic manifestation by age 3 years was not associated with IBD (pooled aHR 1.20; 95% CI 0.95-1.52).

Study details: This study included 83,311 children from the All Babies in Southeast Sweden (1997-1999) and the Norwegian Mother, Father, and Child (1999-2008) birth cohorts with questionnaire-based prospectively collected parent-reported information on asthma, AD, etc., developed by 3 years of age who were followed up from birth until 2021 or a diagnosis of IBD.

Disclosure: This study was supported by The Swedish Research Council and others. The authors declared no conflicts of interest.

Source: Lerchova T, Størdal K, Andersson B, Ludvigsson J, Mårild K. Atopic dermatitis in early childhood and risk of inflammatory bowel disease: A Scandinavian birth cohort study. J Pediatr. 2024;270:14027 (Mar21). doi: 10.1016/j.jpeds.2024.114027. Source

Recommended Reading

Real World Study Confirms Safety and Efficacy of Abrocitinib in Atopic Dermatitis
MDedge Dermatology
Patients with Atopic Dermatitis Value Safety the Most When Choosing Treatments
MDedge Dermatology
Skin Inflammatory Biomarker Predictive of Atopic Dermatitis in Infants With Filaggrin Wild Genotype
MDedge Dermatology
Topical Roflumilast Effective in 4 Weeks for Atopic Dermatitis in Young Children
MDedge Dermatology
Lebrikizumab Found Effective for Atopic Dermatitis in Patients With Darker Skin Tones
MDedge Dermatology
Nemolizumab Efficacy for Prurigo Nodularis Persists at 1 Year
MDedge Dermatology
Commentary: Choosing Treatments of AD, and Possible Connection to Learning Issues, April 2024
MDedge Dermatology
Childhood Atopic Dermatitis Linked to IBD Risk
MDedge Dermatology
What’s ‘Tried and True’ in Atopic Dermatitis? An Expert Reflects
MDedge Dermatology
How Does Moderate to Severe Eczema Affect Growth in Children?
MDedge Dermatology